Brief: Immunovia Announces Positive Outcome Of CLARITI Study
Dec 9 (Reuters) - Immunovia AB (publ) IMMNOV.ST :
* IMMUNOVIA ANNOUNCES POSITIVE OUTCOME AND STRONG ACCURACY
IN THE
CLINICAL VALIDATION OF ITS NEXT-GENERATION TEST FOR PANCREATIC
CANCER
* TEST DEMONSTRATED SENSITIVITY OF 78% AND SPECIFICITY OF
94% IN
DETECTING STAGE 1 AND 2 PDAC
Source text: ID:nWkr452dbr
Further company coverage: IMMNOV.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Immunovia AB (publ)
See all newsBrief: Immunovia Publishes Data On Pancreasure In Hereditary, Familial High-Risk Individuals
Brief: Immunovia To Carry Out Rights Issue Of About SEK 63 Million
Sweden's Immunovia Q2 sales rise on PancreaSure test uptake
Brief: Immunovia Reports Q2 Operating Loss Of SEK 22.8 Million
Brief: PancreaSure Achieves 88% Sensitivity In Immunovia Study